1-ethoxycarbonyloxy-piperidine | 98553-03-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-ethoxycarbonyloxy-piperidine
• 英文别名: 1-Aethoxycarbonyloxy-piperidin；N-Aethoxycarbonyloxy-piperidin；Ethyl piperidin-1-yl carbonate
• CAS: 98553-03-8
• 化学式: C₈H₁₅NO₃
• 分子量: 173.212
• InChiKey: ZJKHMIGEBJOMTO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  1-羟基哌啶 、 氯甲酸乙酯 生成 1-ethoxycarbonyloxy-piperidine
  参考文献：
  名称：

  Zinner, Chemische Berichte, 1958, vol. 91, p. 302,306

  摘要：

  DOI：

文献信息

• Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0600717A1

  公开（公告）日：1994-06-08

  Compounds of formula (I): [wherein: R¹ is aryl; R² is hydrogen, alkyl, alkoxy, halogen or cyano; R³ is a group of formula -B-NR⁴R⁵, where R⁴ and R⁵ are independently hydrogen, alkyl or substituted alkyl or R⁴ and R⁵, together with the nitrogen to which they are attached, form a heterocycle, and B is alkylene or a group of formula -CH₂CH(OR⁶ )CH₂-, where R⁶ is hydrogen, alkanoyl, substituted alkanoyl or arylcarbonyl, or a group of formula -D-R⁷, where D is a single bond or alkylene and R⁷ is a heterocycle; and A is alkylene; and pharmaceutically acceptable salts and esters thereof] are useful for the treatment and prevention of circulatory diseases and psychosis.

  式(I)的化合物：[其中：R¹为芳基；R²为氢、烷基、烷氧基、卤素或氰基；R³为式-B-NR⁴R⁵的基团，其中R⁴和R⁵独立地为氢、烷基或取代烷基，或者R⁴和R⁵与它们所连接的氮一起形成杂环，B为烷基或式-CH₂CH(OR⁶)CH₂-的基团，其中R⁶为氢、烷酰基、取代烷酰基或芳基羰基，或式-D-R⁷的基团，其中D为单键或烷基烯丙基，R⁷为杂环；且A为烷基；以及其药学上可接受的盐和酯]可用于治疗和预防循环系统疾病和精神病。
• Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0790235A1

  公开（公告）日：1997-08-20

  Compounds of formula (I): [in which: R1 represents a saturated heterocyclic group attached to the bond or group represented by A through a ring carbon atom; R2a, R2b, R2c, R3a, R3b, R3c and R3d are hydrogen or various other groups or atoms; and A represents a single bond or an alkylene group having from 1 to 6 carbon atoms] are serotonin 2 receptor antagonists and have the ability to inhibit the activity of squalene synthase. They can not only prevent and inhibit the development and progression of arteriosclerosis but can also inhibit thrombosis in arteriosclerotic lesions and can improve hemodynamics.

  式(I)化合物： 其中R1代表通过环碳原子连接到 A 所代表的键或基团上的饱和杂环基团；R2a、R2b、R2c、R3a、R3b、R3c 和 R3d 是氢或各种其他基团或原子；A 代表单键或具有 1 至 6 个碳原子的亚烷基]是血清素 2 受体拮抗剂，具有抑制角鲨烯合成酶活性的能力。它们不仅能预防和抑制动脉硬化的发生和发展，还能抑制动脉硬化病变部位的血栓形成，并能改善血液动力学。
• Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0844000A1

  公开（公告）日：1998-05-27

  Compounds of formula (I): [wherein: R1 is aryl; R2 is hydrogen, alkyl, alkoxy, halogen or cyano; R3 is a group of formula -B-NR4R5, where R4 and R5 are independently hydrogen, alkyl or substituted alkyl or R4 and R5, together with the nitrogen to which they are attached, form a heterocycle, and B is alkylene or a group of formula -CH2CH(OR6)CH2-, where R6 is hydrogen, alkanoyl, substituted alkanoyl or arylcarbonyl, or a group of formula -D-R7, where D is a single bond or alkylene and R7 is a heterocycle; and A is alkylene; and pharmaceutically acceptable salts and esters thereof] are useful for the treatment and prevention of psychosis.

  式(I)化合物： 其中R1 是芳基；R2 是氢、烷基、烷氧基、卤素或氰基；R3 是式-B-NR4R5 的基团，其中 R4 和 R5 独立地是氢、烷基或取代的烷基，或 R4 和 R5 与它们所连接的氮一起构成杂环，B 是亚烷基或式-CH2CH(OR6)CH2-的基团，其中 R6 是氢、烷酰基、取代的烷酰基或芳羰基，或式-D-R7 的基团，其中 D 是单键或亚烷基，R7 是杂环；和 A 是亚烷基；及其药学上可接受的盐和酯]可用于治疗和预防精神病。
• US5556864A
  申请人：——

  公开号：US5556864A

  公开（公告）日：1996-09-17
• US5843983A
  申请人：——

  公开号：US5843983A

  公开（公告）日：1998-12-01